Company Management

RAGE Biotech

Biotechnology Research Melbourne, Victoria, Au 8 employees

Employees: 8
Contacts: 2
Emails: 2
Phones: 1

ragebiotech.com LinkedIn Crunchbase

RAGE Biotech Overview

Headquarters: Melbourne, Victoria, Au
Website: ragebiotech.com
Industry: Biotechnology Research
Employees: 8
Founded: 2020
Funding: 3.7M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in inhaled biologics

About RAGE Biotech

RAGE Biotech Pty Ltd is a pharmaceutical start-up company developing novel therapeutics for patients with difficult-to-treat inflammatory disease. With our proprietary RNA therapeutics and peptide technologies, we are developing drugs targeting the Receptor for Advanced Glycation End-products (RAGE), a clinically important, pro-inflammatory ‘sensing’ receptor. Our most advanced programme is an inhaled drug for lung diseases where inflammation is a problem. RAGE Biotech was formed in 2020 with investments from IP Group, Monash Investment Holdings, the University of Western Australia and the Perron Instute.

RAGE Biotech Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

RAGE Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Siro Perez	Biotech Vc @ Ip Group Ventures	Sydney, New South Wales, Australia	Email Phone
Christopher Wraight	Chief Scientific Officer at Rage Biotech		View
Alisa Selimovic	Biotech Vc	Brisbane City, Queensland, Australia	Email
Kevin Pfleger	Director, Biomedical and Health		View